{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:22:58Z","timestamp":1787430178705,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.beem.2026.102158","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:39:02Z","timestamp":1786880342000},"page":"102158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic endocrine tumors focusing on the thyroid"],"prefix":"10.1016","author":[{"given":"Sara P.","family":"Ginzberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennine H.D.","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Skefos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.beem.2026.102158_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","article-title":"Pathogenesis of cancers derived from thyroid follicular cells","volume":"23","author":"Fagin","year":"2023","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib2","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102158_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib4","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00268-006-0847-1","article-title":"An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up","volume":"31","author":"Sippel","year":"2007","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib7","doi-asserted-by":"crossref","first-page":"R577","DOI":"10.1530\/ERC-16-0067","article-title":"Familial non-medullary thyroid cancer: unraveling the genetic maze","volume":"23","author":"Peiling Yang","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40618-020-01435-x","article-title":"Familial non-medullary thyroid cancer: a critical review","volume":"44","author":"Capezzone","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.beem.2026.102158_bib9","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1210\/jc.2005-0935","article-title":"Familial risks for nonmedullary thyroid cancer","volume":"90","author":"Hemminki","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.beem.2026.102158_bib10","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","article-title":"Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands","volume":"86","author":"Goldgar","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.beem.2026.102158_bib11","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa191","article-title":"Familial aggregation and heritability of nonmedullary thyroid cancer in an asian population: a Nationwide Cohort Study","volume":"105","author":"Lin","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2026.102158_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3803\/EnM.2018.33.2.164","article-title":"Genetic polymorphism predisposing to differentiated thyroid cancer: a review of major findings of the genome-wide association studies","volume":"33","author":"Saenko","year":"2018","journal-title":"Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2026.102158_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092178","article-title":"Genetics of familial non-medullary thyroid carcinoma (FNMTC)","volume":"13","author":"Diquigiovanni","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1089\/thy.2013.0102","article-title":"Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma","volume":"23","author":"Liyanarachchi","year":"2013","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/endrev\/bnad013","article-title":"Medullary thyroid cancer: updates and challenges","volume":"44","author":"Gild","year":"2023","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib16","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0139","article-title":"Genotype\/phenotype correlations in multiple endocrine neoplasia type 2","volume":"31","author":"Castinetti","year":"2024","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib17","doi-asserted-by":"crossref","first-page":"e4049","DOI":"10.1210\/clinem\/dgaf236","article-title":"Population prevalence of the major thyroid cancer-associated syndromes","volume":"110","author":"White","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102158_bib18","first-page":"477","article-title":"CHEK2 founder variants and thyroid cancer risk","volume":"34","author":"Brock","year":"2024","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.beem.2026.102158_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.29426","article-title":"CHEK2 mutations and the risk of papillary thyroid cancer","volume":"137","author":"Siolek","year":"2015","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026195","article-title":"The inherited p53 mutation in the Brazilian population","volume":"6","author":"Achatz","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"10.1016\/j.beem.2026.102158_bib21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jamaoncol.2016.6389","article-title":"Frequency of thyroid carcinoma in Brazilian TP53 p.R337H carriers With Li fraumeni syndrome","volume":"3","author":"Formiga","year":"2017","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.beem.2026.102158_bib24","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8778","article-title":"Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)","volume":"52","author":"Cameselle-Garcia","year":"2024","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00428-025-04384-z","article-title":"Unmasking familial follicular cell-derived thyroid neoplasms associated with syndromes: DICER1 and PTEN-hamartoma tumor syndromes","volume":"488","author":"Riascos","year":"2026","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.beem.2026.102158_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19452","article-title":"Yield and utility of germline testing following tumor sequencing in patients with cancer","volume":"3","author":"Lincoln","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.beem.2026.102158_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1677\/ERC-08-0080","article-title":"Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity","volume":"15","author":"Capezzone","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archsurg.1995.01430080094015","article-title":"Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment","volume":"130","author":"Grossman","year":"1995","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00268-002-6615-y","article-title":"Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population","volume":"26","author":"Uchino","year":"2002","journal-title":"World J Surg"},{"issue":"9153","key":"10.1016\/j.beem.2026.102158_bib30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(98)08004-0","article-title":"Familial papillary thyroid microcarcinoma: a new clinical entity","volume":"353","author":"Lupoli","year":"1999","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.beem.2026.102158_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17203381","article-title":"Familial non-medullary thyroid carcinoma: distinct clinicopathological features and prognostic implications in a large cohort of 46,572 patients","volume":"17","author":"Lee","year":"2025","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.beem.2026.102158_bib32","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00268-020-05473-7","article-title":"Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?","volume":"44","author":"Kim","year":"2020","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00268-005-0398-x","article-title":"Does familial non-medullary thyroid cancer adversely affect survival?","volume":"30","author":"Triponez","year":"2006","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.beem.2026.102158_bib34","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s002680010233","article-title":"Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment","volume":"24","author":"Musholt","year":"2000","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.beem.2026.102158_bib35","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1210\/jcem.86.11.8010","article-title":"Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study","volume":"86","author":"Pal","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMoa1502449","article-title":"Germline HABP2 mutation causing familial nonmedullary thyroid cancer","volume":"373","author":"Gara","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib37","doi-asserted-by":"crossref","first-page":"E973","DOI":"10.1210\/jc.2012-3823","article-title":"SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility","volume":"98","author":"He","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2026.102158_bib38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1089\/thy.2018.0736","article-title":"Identification of rare variants predisposing to thyroid cancer","volume":"29","author":"Wang","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.35159","article-title":"Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways","volume":"156","author":"Pires","year":"2025","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/thy.2016.0668","article-title":"Results of screening in familial non-medullary thyroid cancer","volume":"27","author":"Klubo-Gwiezdzinska","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2026.102158_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.845954","article-title":"Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients","volume":"13","author":"Capezzone","year":"2022","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib42","first-page":"1070","article-title":"Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up","volume":"114","author":"Howe","year":"1993","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/thy.2005.15.531","article-title":"RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors","volume":"15","author":"Kouvaraki","year":"2005","journal-title":"Thyroid"},{"issue":"19","key":"10.1016\/j.beem.2026.102158_bib44","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.beem.2026.102158_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/genes10090698","article-title":"Twenty-five years experience on RET genetic screening on hereditary MTC: an update on the prevalence of germline RET mutations","volume":"10","author":"Elisei","year":"2019","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.surg.2022.05.005","article-title":"Medullary thyroid cancer with RET V804M mutation: more indolent than expected?","volume":"173","author":"Frisco","year":"2023","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.beem.2026.102158_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ecl.2025.03.018","article-title":"Familial Thyroid Cancers Syndromes","volume":"54","author":"Pishdad","year":"2025","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2026.102158_bib48","unstructured":"National Comprehensive Cancer Network. Thyroid Carcinoma (Version 2.2026). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/thyroid.pdf. Accessed May 17, 2026."},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065687","article-title":"Molecular pathways of carcinogenesis in familial adenomatous polyposis","volume":"24","author":"Ditonno","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.beem.2026.102158_bib50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1572-0241.2006.00375.x","article-title":"Familial adenomatous polyposis","volume":"101","author":"Galiatsatos","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.beem.2026.102158_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.beem.2026.102158_bib52","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s002689900462","article-title":"Thyroid cancer in patients with familial adenomatous polyposis","volume":"22","author":"Perrier","year":"1998","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.beem.2026.102158_bib53","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1007\/s00268-018-4644-4","article-title":"Cribriform-morular variant of papillary thyroid carcinoma: clinical and pathological features of 30 cases","volume":"42","author":"Akaishi","year":"2018","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1897-4287-11-13","article-title":"Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals","volume":"11","author":"Septer","year":"2013","journal-title":"Hered Cancer Clin Pract"},{"issue":"11","key":"10.1016\/j.beem.2026.102158_bib55","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1089\/thy.2019.0261","article-title":"Multifocality in a patient with cribriform-morular variant of papillary thyroid carcinoma is an important clue for the diagnosis of familial adenomatous polyposis","volume":"29","author":"Park","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.beem.2026.102158_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12022-021-09683-0","article-title":"Cribriform-morular thyroid carcinoma is a distinct thyroid malignancy of uncertain cytogenesis","volume":"32","author":"Boyraz","year":"2021","journal-title":"Endocr Pathol"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib57","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/jc.2016-2043","article-title":"Age- and gender-specific risk of thyroid cancer in patients with familial adenomatous polyposis","volume":"101","author":"Uchino","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2026.102158_bib58","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.prp.2015.04.011","article-title":"Cribriform-morular variant of papillary thyroid carcinoma","volume":"211","author":"Pradhan","year":"2015","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.beem.2026.102158_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejso.2017.07.004","article-title":"Post-treatment surveillance of thyroid cancer","volume":"44","author":"Wang","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.beem.2026.102158_bib60","unstructured":"National Comprehensive Cancer Network. Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate (Version 3.2026). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bopp.pdf. Accessed May 31, 2026."},{"issue":"21","key":"10.1016\/j.beem.2026.102158_bib61","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/0008-5472.CAN-23-2216","article-title":"The genomic landscape of benign and malignant thyroid tumors from individuals carrying germline PTEN variants is distinct from sporadic thyroid cancers","volume":"84","author":"Plitt","year":"2024","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060844","article-title":"PTEN hamartoma tumor syndrome: a clinical overview","volume":"11","author":"Pilarski","year":"2019","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib63","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hed.22971","article-title":"Thyroid disease associated with Cowden syndrome: a meta-analysis","volume":"35","author":"Hall","year":"2013","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000506422","article-title":"Occurrence and natural history of thyroid cancer in patients with cowden syndrome","volume":"9","author":"Szabo Yamashita","year":"2020","journal-title":"Eur Thyroid J Sep"},{"issue":"2","key":"10.1016\/j.beem.2026.102158_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib66","doi-asserted-by":"crossref","first-page":"846","DOI":"10.14309\/ajg.0000000000001755","article-title":"Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the US multi-society task force on colorectal cancer","volume":"117","author":"Boland","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jnci\/djac188","article-title":"Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome","volume":"115","author":"Hendricks","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.beem.2026.102158_bib68","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/gim.2012.51","article-title":"Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome","volume":"14","author":"Mester","year":"2012","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib69","doi-asserted-by":"crossref","DOI":"10.1148\/rg.230202","article-title":"Li-fraumeni syndrome: imaging features and guidelines","volume":"44","author":"Gosangi","year":"2024","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","article-title":"Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions","volume":"17","author":"Sorrell","year":"2013","journal-title":"Mol Diagn Ther"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib71","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"de Andrade","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.beem.2026.102158_bib72","article-title":"Clinical features and treatment strategies of Li-fraumeni syndrome patients with inherited TP53 mutations","volume":"14","author":"Chen","year":"2026","journal-title":"Mol Genet Genom Med"},{"issue":"10","key":"10.1016\/j.beem.2026.102158_bib73","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1158\/1078-0432.CCR-24-3301","article-title":"Update on cancer screening recommendations for individuals with Li-fraumeni syndrome","volume":"31","author":"Achatz","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib74","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2026.102158_bib75","doi-asserted-by":"crossref","unstructured":"Sauer M., Barletta J.A. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors. Head Neck Pathol. 2022;16(1):190-199.","DOI":"10.1007\/s12105-022-01417-w"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib76","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1210\/jc.2016-2954","article-title":"Quantification of thyroid cancer and multinodular goiter risk in the DICER1 syndrome: a family-based cohort study","volume":"102","author":"Khan","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102158_bib77","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/clinem\/dgab025","article-title":"Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology","volume":"106","author":"Chong","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10050143","article-title":"DICER1 syndrome: DICER1 mutations in rare cancers","volume":"10","author":"Robertson","year":"2018","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.beem.2026.102158_bib79","doi-asserted-by":"crossref","DOI":"10.1200\/PO.18.00172","article-title":"DICER1 mutations in the era of expanding integrative clinical sequencing in pediatric oncology","author":"Bailey","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib80","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ajcp\/aqy004","article-title":"Multinodular goiter progression toward malignancy in a case of DICER1 syndrome: histologic and molecular alterations","volume":"149","author":"Gullo","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.beem.2026.102158_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2018-00774","article-title":"Clinical and molecular characteristics may alter treatment strategies of thyroid malignancies in DICER1 syndrome","volume":"104","author":"van der Tuin","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102158_bib82","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/his.14416","article-title":"Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features","volume":"79","author":"Juhlin","year":"2021","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.beem.2026.102158_bib83","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2018.78.4678","article-title":"Neoplasm risk among individuals with a pathogenic germline variant in DICER1","volume":"37","author":"Stewart","year":"2019","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.beem.2026.102158_bib84","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.49730","article-title":"Genomic ascertainment of CHEK2-related cancer predisposition","volume":"8","author":"Kim","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib85","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2026.102158_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.600682","article-title":"Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancer","volume":"12","author":"Srivastava","year":"2021","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2026.102158_bib87","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","article-title":"Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care-checking CHEK2","volume":"8","author":"Bychkovsky","year":"2022","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.beem.2026.102158_bib88","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/PAS.0000000000000975","article-title":"The spectrum of thyroid gland pathology in carney complex: the importance of follicular carcinoma","volume":"42","author":"Carney","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.beem.2026.102158_bib89","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2032-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2026.102158_bib90","first-page":"525","article-title":"Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas","volume":"83","author":"Ward","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2026.102158_bib91","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/gcc.10112","article-title":"Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer","volume":"35","author":"Sandrini","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"20","key":"10.1016\/j.beem.2026.102158_bib92","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/hmg\/9.20.3037","article-title":"Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex","volume":"9","author":"Kirschner","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beem.2026.102158_bib93","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: an update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102158_bib94","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa002","article-title":"Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up","volume":"105","author":"Espiard","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:30:27Z","timestamp":1787427027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":94,"alternative-id":["S1521690X26000801"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102158","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic endocrine tumors focusing on the thyroid","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102158"}}